Achieve Life Sciences
ACHV
12 hedge funds and large institutions have $607K invested in Achieve Life Sciences in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
59% more capital inflows, than outflows
Capital inflows: $186K | Capital outflows: $117K
0.19% more ownership
Funds ownership: 3.59% → 3.78% (+0.19%)
20% less funds holding
Funds holding: 15 → 12 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$103K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$58.2K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18.2K |
| 4 |
Panagora Asset Management
Boston,
Massachusetts
|
+$2.88K |
| 5 |
BlackRock
New York
|
+$1.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
-$34K |
| 2 |
Two Sigma Securities
New York
|
-$29K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$27K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$22K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.52K |
ACHV Hedge Fund Activity: Q4 2017 in Review
12 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2017, worth a combined $607K — down 24% from $797K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ACHV and 2 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $103K. The largest seller was Virtu Financial, exiting entirely with an estimated $34K sold.
- 12 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2017, down from 15 in Q3 2017.
- Funds reported $607K of Achieve Life Sciences stock for Q4 2017, down 24% quarter-over-quarter.
- 2 funds opened new Achieve Life Sciences positions in Q4 2017 and 5 closed out, a net change of -3 holders.
- The largest Achieve Life Sciences buyer in Q4 2017 was Renaissance Technologies, an estimated $103K added.
- The largest Achieve Life Sciences seller in Q4 2017 was Virtu Financial, an estimated $34K sold.
Based on aggregated 13F filings for Q4 2017.